Good manufacturing practice production of an off-the-shelf CD34+ progenitor-derived NK cell product with preserved anti-tumor functionality post-infusion in NOD/SCID/IL2Rgnull mice
Laura Hooijmaijers(Radboud University Nijmegen), Harry Dolstra(Radboud University Nijmegen), Vanessa Rodríguez‐Fanjul(Radboud University Nijmegen), Joop H. Jansen(Radboud University Nijmegen), Diede van Ens(Radboud University Nijmegen), Willemijn Hobo(Maastricht University Medical Centre), Marcos Vidal-Manrique(Radboud University Nijmegen), Paul K.J.D. de Jonge(Radboud University Nijmegen), Suzanne van Dorp(University Medical Center Utrecht), Anniek B. van der Waart(Radboud University Nijmegen), Bart Spils(Radboud University Nijmegen), Anna L. de Goede(Radboud University Nijmegen)
Cited by 6
Related Papers
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378